Evidence map›Paper›PMID 38515121›Full record

ReviewCritical care (London, England)2024

Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials.

Matthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, Azra Bihorac, Ellen Caniglia, Ashish K Khanna, John A Kellum, Jay Koyner, Michael O Harhay, Fernando G Zampieri and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Clinical subtypes and prognosis of new-onset atrial fibrillation in critically ill patients.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. A novel two-hit murine model of viral-primed sepsis-associated acute kidney injury.American journal of physiology. Renal physiology · 2026
    Article
  17. Article
  18. Review
  19. Renoprotective Potential of Nateglinide in an Acute Kidney Injury Model.International journal of molecular sciences · 2026
    Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 17 institutions in 8 countries.

Matthieu LegrandDivision of Critical Care Medicine, Department of Anesthesia and Perioperative Care, UCSF, 521 Parnassus Avenue, San Francisco, CA, 94143, USA. Matthieu.Legrand@ucsf.edu.
Sean M BagshawDepartment of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada.
Pavan K BhatrajuDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, USA.
Azra BihoracDepartment of Medicine, University of Florida, Gainesville, FL, USA.
Ellen CanigliaDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
Ashish K KhannaDepartment of Anesthesiology, Section on Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
John A KellumDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jay KoynerUniversity Section of Nephrology, Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Michael O HarhayClinical Trials Methods and Outcomes Lab, Department of Biostatistics, Epidemiology, and Informatics, PAIR (Palliative and Advanced Illness Research) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Fernando G ZampieriDepartment of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada.
Alexander ZarbockHospital Münster, Münster, Germany.
Kevin ChungSeaStar Medical, Denver, CO, USA.
Kathleen LiuDivisions of Nephrology and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA.
Ravindra MehtaDepartment of Medicine, University of California, San Diego, USA.
Peter PickkersIntensive Care Medicine, Radboudumc, Nijmegen, The Netherlands.
Abigail RyanChronic Care Policy Group, Division of Chronic Care Management, Center for Medicare and Medicaid Services, Center for Medicare, Baltimore, MD, USA.
Juliane BernholzAM-Pharma, Stadsplateau 6, 3521 AZ, Utrecht, The Netherlands.
Laura DemberRenal-Electrolyte and Hypertension Division, Department of Medicine, Department of Biostatistics, Epidemiology and Informatics, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Martin GallagherThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Patrick RossignolFCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Marlies OstermannDepartment of Critical Care, King's College London, Guy's & St Thomas' Hospital, London, UK.
University of Pennsylvania · USUniversity of California, San Francisco · USAlberta Health Services · CAAM–Pharma (Netherlands) · NLCenters for Medicare and Medicaid Services · USInserm · FROutcomes Research Consortium · USRadboud University Nijmegen · NLSeattle University · USSt Thomas' Hospital · GBUniversity Hospital Münster · DEUniversity of Alberta · CAUniversity of California San Diego · USUniversity of Chicago · USUniversity of Florida · USUniversity of Pittsburgh · USUNSW Sydney · AU

Funding

Identification and Validation of Biological Sub-phenotypes of Sepsis-induced Acute Kidney Injury: A Precision Medicine Approach to Improve Clinical OutcomesR01DK133177 · NIDDK · UNIVERSITY OF WASHINGTON · PI Pavan Kumar Bhatraju · 2022 to 2026
$2.6M
The choice of vasopressor to prevent postoperative acute kidney injury after major non-cardiac surgery: a multicenter pragmatic cluster cross-over randomized trial (the VEGA-2 trial)R01DK139484 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SACHIN KHETERPAL, Matthieu Legrand · 2024 to 2026
$2.0M
Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURNR01GM151494 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthieu Legrand · 2023 to 2026
$1.5M
NIDDK NIH HHS R01 DK133177NIDDK NIH HHS R01 DK139484NIGMS NIH HHS R01 GM151494
6 · The paper itself

Abstract

Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome. We discuss lessons learned and potential opportunities to improve the design of clinical trials and generate actionable evidence in future research. We specifically discuss the role of enrichment strategies to target populations that are most likely to derive benefit and the importance of patient-centered clinical trial endpoints and appropriate trial designs with the aim to provide guidance in designing future trials.

Indexed as

Acute Kidney InjurySepsisClinical Trials as TopicCritical IllnessHumans

Identifiers

PMID38515121
PMCPMC10958912
OpenAlexW4393039933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.